\-\ Texto\\:\\ \ \(0\)\
\-\ t1\\ bright\\ and\\ t2\\/flair\\ bright\\ enlargement\\ of\\ the\\ pituitary\\ gland\\ with\\ a\\ fluid\\ fluid\\ level\\ and\\ mass\\ effect\\ on\\ the\\ optic\\ chiasm\\.\ \(0\)\
\-\ hemorrhage\ \(627\)\
\-\ hemorrhage\ \(627\)\
\-\ 23\\ year\\ old\\ female\\ treated\\ with\\ bromocriptine\\ for\\ a\\ known\\ pituitary\\ prolactinoma\\ is\\ now\\ in\\ the\\ third\\ trimester\\ of\\ pregnancy\\ and\\ no\\ longer\\ taking\\ bromocriptine\\.\\ \\ she\\ has\\ a\\ 3\\-5\\ day\\ history\\ of\\ blurry\\ vision\\,\\ worse\\ today\\.\ \(0\)\
\-\ hemorrhage\\ can\\ occur\\ into\\ a\\ pre\\-existing\\ adenoma\\ or\\ into\\ a\\ hormonally\\ enlarged\\ gland\\.\\ \\ infarction\\ and\\ necrosis\\ is\\ generally\\ part\\ of\\ the\\ pathophysiology\\.\\ \\ classic\\ sheehan\\'s\\ syndrome\\ occurs\\ post\\-partum\\.\\ \\ pituitary\\ apoplexy\\ is\\ a\\ more\\ generalized\\ term\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pituitary\\:\\ 0\\.3320766880700996\ \(0\)\
\-\ bromocriptine\\:\\ 0\\.33111200636443466\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.24103436221020533\ \(0\)\
\-\ bright\\:\\ 0\\.2188076954835264\ \(0\)\
\-\ gland\\:\\ 0\\.19496592480804117\ \(0\)\
\-\ hormonally\\:\\ 0\\.18338060094904343\ \(0\)\
\-\ sheehan\\:\\ 0\\.17732863567695295\ \(0\)\
\-\ prolactinoma\\:\\ 0\\.17263436671630755\ \(0\)\
\-\ blurry\\:\\ 0\\.15097427193478505\ \(0\)\
\-\ apoplexy\\:\\ 0\\.145687372478837\ \(0\)\
\-\ pathophysiology\\:\\ 0\\.14053073344748507\ \(0\)\
\-\ fluid\\:\\ 0\\.13857377667806445\ \(0\)\
\-\ today\\:\\ 0\\.13795154945712773\ \(0\)\
\-\ trimester\\:\\ 0\\.1371576065034952\ \(0\)\
\-\ into\\:\\ 0\\.12758268909307666\ \(0\)\
\-\ chiasm\\:\\ 0\\.12736776384133744\ \(0\)\
\-\ longer\\:\\ 0\\.1221898645844688\ \(0\)\
\-\ taking\\:\\ 0\\.11623373998547298\ \(0\)\
\-\ generalized\\:\\ 0\\.11457206145916136\ \(0\)\
\-\ part\\:\\ 0\\.10722907819248816\ \(0\)\
\-\ vision\\:\\ 0\\.10393261421388987\ \(0\)\
\-\ optic\\:\\ 0\\.10329987504798523\ \(0\)\
\-\ generally\\:\\ 0\\.10165200873804069\ \(0\)\
\-\ worse\\:\\ 0\\.10052976980294628\ \(0\)\
\-\ and\\:\\ 0\\.09918831628538945\ \(0\)\
\-\ 23\\:\\ 0\\.0989512552447008\ \(0\)\
\-\ is\\:\\ 0\\.09859062553234868\ \(0\)\
\-\ pregnancy\\:\\ 0\\.09820430134647284\ \(0\)\
\-\ the\\:\\ 0\\.09577951018155173\ \(0\)\
\-\ adenoma\\:\\ 0\\.09567221160313555\ \(0\)\
\-\ occurs\\:\\ 0\\.09461485381920039\ \(0\)\
\-\ infarction\\:\\ 0\\.09420635571483085\ \(0\)\
\-\ term\\:\\ 0\\.0941054586803711\ \(0\)\
\-\ of\\:\\ 0\\.09393595220089436\ \(0\)\
\-\ enlargement\\:\\ 0\\.09200000382760447\ \(0\)\
\-\ necrosis\\:\\ 0\\.09172855501157952\ \(0\)\
\-\ third\\:\\ 0\\.09137198729980658\ \(0\)\
\-\ classic\\:\\ 0\\.08975623252762611\ \(0\)\
\-\ occur\\:\\ 0\\.08825577372984636\ \(0\)\
\-\ effect\\:\\ 0\\.08418028441809819\ \(0\)\
\-\ now\\:\\ 0\\.082376008529963\ \(0\)\
\-\ enlarged\\:\\ 0\\.08180740658251348\ \(0\)\
\-\ known\\:\\ 0\\.07769326984713887\ \(0\)\
\-\ day\\:\\ 0\\.07643963141327545\ \(0\)\
\-\ t1\\:\\ 0\\.07476915171902529\ \(0\)\
\-\ treated\\:\\ 0\\.07472904304842325\ \(0\)\
\-\ level\\:\\ 0\\.07248854624317612\ \(0\)\
\-\ syndrome\\:\\ 0\\.07234494847497842\ \(0\)\
\-\ she\\:\\ 0\\.07143472034840163\ \(0\)\
\-\ more\\:\\ 0\\.06589429171169223\ \(0\)\
\-\ can\\:\\ 0\\.06297359062108447\ \(0\)\
\-\ female\\:\\ 0\\.05790681499574382\ \(0\)\
\-\ has\\:\\ 0\\.05481371534172165\ \(0\)\
\-\ with\\:\\ 0\\.046996039454975345\ \(0\)\
\-\ history\\:\\ 0\\.04584796051628747\ \(0\)\
\-\ mass\\:\\ 0\\.04583780997743758\ \(0\)\
\-\ or\\:\\ 0\\.04174678619266404\ \(0\)\
\-\ no\\:\\ 0\\.039023497303329435\ \(0\)\
\-\ year\\:\\ 0\\.03698245502809141\ \(0\)\
\-\ for\\:\\ 0\\.036371883165809554\ \(0\)\
\-\ on\\:\\ 0\\.03624286104191863\ \(0\)\
\-\ old\\:\\ 0\\.03551595862147242\ \(0\)\
\-\ in\\:\\ 0\\.029852765505799954\ \(0\)\
